Global Capnography Market – Overview
The global capnography market is showing the moderate growth; mainly due to increase in the population suffering with lung disease and heart disease. There are incidence reported where smoking causes the asthma. Increase in the consumption of cigarette globally, rising the patient suffering with lung disease. Smoking, environmental pollution, and rising cases of infections are the leading causes of lung cancer and asthma. Thus the demand of Capnography devices is increasing rapidly in coming future. According to World Health Organization (WHO) tobacco kills more than 7 million people each year, of which more than 6 million deaths are the result of direct tobacco use. Lung cancer is the leader with a whopping 37% of deaths. The rising rates of smoking in females is an important driver and it has been witnessed that the rates of lung cancer and asthma in men have been falling with a concurrent huge increase in female lung cancers. Also the rise of particulate matter and nitrogen pollution is propelling the rise of lung cancer and asthma.
Companies are showing much interest toward the market of Capnography, as they feel there are huge opportunities and gaps between the market demand and supply of devices. Thus, companies are showing more interest in merger and acquisition activities for introducing the best cure that meets the requirement of market. The development has been made by Nonin Medical, Inc. in 2016, where they announced that they launched the next generation lifesense II and respsense II capnographs, simple, cost-effective etco2 monitoring for a wide range of applications, which is more accurate, ease of use, and cost effective. The companies are introducing better devices for getting the global leadership in the capnography devices and provide a strong treatment option in the market. In 2017, Masimo announces FDA clearance and worldwide release of nomoline capnography sampling lines. This Sampling technology eliminates many common problems associated with conventional sidestream gas sampling line systems. Incorporating a unique, patented polymer, nomoline allows water in the sampling line to continuously evaporate into the surrounding air, while leaving oxygen, carbon dioxide, and anesthetic gases unaffected.
Increasing in the prevalence of lung disease around the globe is creating the huge scope for the market players to make a profit. Also excellent reimbursement scenario for cancers, especially in the U.S. is very significant driver for the capnography devices as it minimize the financial burden from the patient.
Athena GTX Inc (U.S.), Dragerwerk AG (Germany), Medtronic Inc. (U.S.), Masimo Corporation (U.S.), Nonin Medical, Inc. (U.S.), OSI Systems Inc (U.S.), Koninklijke Philips N.V. (the Netherlands), Welch Allyn, Inc. (U.S.) are some of the leading players at the cutting edge of the competition in the market of capnography, globally.
Capnography is the devices use for monitoring the partial pressure of CO2 during anesthesia and sedation. Usually it presents the graphs of expiratory CO2 plotted against time. It serves as an important monitoring tool in the intensive care or during anesthesia. An increase in the prevalence of people suffering from diseases like COPD and asthma increases the demand of capnography around the world. According to the Centers for Disease Control and Prevention (CDC), in 2014, approximate 15.7 million (6.4%) Americans have been diagnosed with chronic obstructive pulmonary disease (COPD)
Global Capnography Market – Regional Analysis
The market of capnography devices is much higher in Asia Pacific region, owing to smoking, environmental pollution, and infection. These are the factor which increases the occurrence of disease related to the lungs, thus, the demand for capnography devices enhance in this region. Most of the countries of this region have common lifestyle and economic conditions and focusing more to enhance the treatment option. Thus, more research and development programs are initiated for the development of new devices. China is the most popular country in the world, with more than 1.3 billion people will lead the Asia Pacific market. The rising levels of risk factors such as an urbanization, air pollution and smoking in this region leads the number of lung cancer cases and fatalities in the world, with 700,000 Chinese people diagnosed with lung cancer in 2015. Thus increase in the number of patient suffering with lung enhance the demand for better treatment and devices.
Government of developing countries within this region are willing to adopt advanced treatment option available in developed countries, which fuel the market of capnography. These advance devices will overcome the saturation that occurs during the last few years. Countries like India and China are more focused market for global market players owing to the huge patient population and growing purchasing power as compare to other countries in this region. Japan is well developed country and have advanced healthcare system and technology, whereas developing countries are still focusing on new technology for the treatment.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
Market Research Future®
99 Hudson Street,5Th Floor
New York, New York 10013
United States of America